SlideShare a Scribd company logo
DEMONSTRATION
OF LE CELLS
PRESENTED BY,
S.SHRUTHI VASAN
III BSC.CLT
Dr.NGP ARTS & SCIENCE COLLEGE
LE CELLS:
 An LE cell is a Neutrophil or Macrophage that has
phagocytised (engulfed) the denatured nuclear material
of another cell. The denatured material is an
absorbed haematoxylin body (basophilic particle also
called an LE body).
 They are a characteristic of lupus erythematosus, but
also found in similar connective tissue disorders.
 The LE cell was discovered in bone marrow in 1948 by
Malcolm McCallum Hargraves (1903–1982), a
Physician and Practicing Histologist at the Mayo Clinic.
 Classically, the LE cell is analyzed microscopically, but it
is also possible to investigate this phenomenon by flow
cytometry.
FLOW CYTOMETER
SLE
 Persons having lupus erythematosus, one of the "collagen"
diseases, have an abnormal plasma protein that causes swelling
and breakdown of certain blood cell nuclei in vitro.
 This degenerated nuclear material attracts phagocytic cells,
particularly segmented neutrophils, which engulf this nuclear
mass.
 The resulting phagocyte and inclusion material is termed an
"L.E." cell.
 Lupus erythematosus is a chronic, sometimes fatal, disease of
unknown etiology.
 The peculiar skin eruption across the nose and cheeks (butterfly
rash) and arthritis can be accompanied by various visceral
manifestations.
 Often the rash is not present, and diagnosis depends on
demonstration of the L.E. cell.
 Frequently the earliest symptoms appear after intense exposure
to sunlight.
 Leukopenia, thrombocytopenia, and an elevated sedimentation
rate are some of the clinical signs of the disease.
Two methods of demonstrating the L.E. cell
and antinuclear antibodies are the
 Rotary bead method and
 Fluorescent antibody method.
The rotary bead method is positive in 75-80
erythematosus.
The fluorescent antibody method is positive in
95-100 patients with lupus erythematosus.
The fluorescent antibody method requires
equipment that limits its use to larger laboratories.
ROTARY BEAD METHOD
Principle
Leukocytes are broken down in vitro allowing
the abnormal plasma protein to react on the altered
nuclear material. Incubation enhances the nuclear
deterioration and phagocytises. Slides are prepared
and examined for the peculiar "L.E." cell.
 Free masses of lysed nuclear material, with or
without polymorphonuclear leukocytes clustered
about them (rosette formation), are suggestive of
the L.E. phenomenon.
 Observing "rosettes" should encourage the
technician to repeat examinations and further
search for the true "L.E." cells.
 A positive report should not be made without the
identification of this cell. The inclusion body with the
leukocyte is homogeneous and has no chromatin
pattern. This feature distinguishes the true "L.E." cell
from the "tart" cell (nucleophagocytosis).
 This latter cell contains an engulfed, damaged
nucleus, usually that of a lymphocyte, which still
contains a recognizable chromatin pattern and a
distinct nuclear membrane.
COLLECTION OF SAMPLE::
Lupus erythematosus (LE) cell testing is
performed using any of the following:
 Heparinized bone marrow
 Heparinized venous blood
 Oxalated venous blood
 Defibrinated venous blood
 Clotted venous blood
 LE factor and donor cells
LE Factor:
An Antibody found in the serum found in SLE
Patients.
 Obtaining bone marrow is usually distressing for the
patient; therefore, the buffy coat from venous blood is
an adequate substitute.
 If the equipment for buffy coat is unavailable, an
untreated venous blood sample is left to clot (from 20-
120 minutes) and the plasma removed. The residual
clot is passed through a wire mesh and centrifuged
for 5 minutes to obtain a buffy coat. This buffy coat is
then smeared on glass slides to search for LE cells. [2]
 The test may be performed by mixing the patient's
plasma, serum, or serous effusions as a source of LE
factor with bone marrow from a donor subject.
CONSIDERATIONS:
 The ideal temperature to perform this test is 22°C,
and the process may be hastened by incubation at
37°C.
INTERPRETATION
o A lupus erythematosus (LE) cell test is considered
positive when approximately 2%-30% of the cells
seen on the slide in the neutrophil count are LE cells.
o A smear is considered positive when 10 or more
characteristic LE cells are seen during a 15-minute
search, associated with the presence of extracellular,
amorphous, nuclear masses.
o The presence of LE cells indicates lupus.
o Negative findings on LE cell testing exclude (deny) a
diagnosis of systemic lupus erythematosus(SLE).
o Positive reactions are also seen in
1. Rheumatoid arthritis
2. Chronic hepatitis(lupoid)
3. Scleroderma
4. Dermatomyositis
5. Polyarteritis nodosa
6. Acquired hemolytic anemia
7. Hodgkin disease
o It may also be positive in persons taking
phenylbutazone(Fever & RE) and hydralazine(BP)
APPLICATION
 Lupus erythematosus (LE) cell testing was once
performed to diagnose systemic lupus
erythematous but has been replaced for this purpose
by antinuclear antibody testing.
Demonstration of le cells

More Related Content

What's hot

blood group du testing
blood group du testing blood group du testing
blood group du testing
rajesh kumar
 
Pas staining
Pas staining Pas staining
PLATELET COUNT by Dr. Pandian M .pptx
PLATELET COUNT by Dr. Pandian M .pptxPLATELET COUNT by Dr. Pandian M .pptx
PLATELET COUNT by Dr. Pandian M .pptx
Pandian M
 
special and routine stains in haematology 1
special and routine stains in haematology 1special and routine stains in haematology 1
special and routine stains in haematology 1
Dr.SHAHID Raza
 
Investigation of transfusion reaction
Investigation of transfusion reactionInvestigation of transfusion reaction
Investigation of transfusion reaction
SHRUTHI VASAN
 
Massons Trichrome Stain
Massons Trichrome StainMassons Trichrome Stain
Massons Trichrome StainZahoor Ahmed
 
Microtomes, Section cutting , Sharpening of Razors
Microtomes, Section cutting , Sharpening of RazorsMicrotomes, Section cutting , Sharpening of Razors
Microtomes, Section cutting , Sharpening of Razors
vikas25187
 
Bone marrow aspirate&biopsy preparation
Bone marrow aspirate&biopsy preparationBone marrow aspirate&biopsy preparation
Bone marrow aspirate&biopsy preparation
Malak Salam
 
Reticulocyte count
Reticulocyte countReticulocyte count
Reticulocyte countPrbn Shah
 
Staining ( rouine and special in cytology) rajiv kumar
Staining ( rouine and special in cytology) rajiv kumarStaining ( rouine and special in cytology) rajiv kumar
Staining ( rouine and special in cytology) rajiv kumar
rajusehrawat
 
Final ppt sickle cell
Final ppt sickle cellFinal ppt sickle cell
Final ppt sickle cell
Darlasrinivasarao Srinu
 
Gel card technology ppt nc
Gel card technology ppt ncGel card technology ppt nc
Gel card technology ppt nc
Nainshi Bhatt
 
Coombs test
Coombs testCoombs test
Coombs test
Manoj Mahato
 
Special stain in histopathology
Special stain in histopathologySpecial stain in histopathology
Special stain in histopathology
aghara mahesh
 
Haemocytometry.
Haemocytometry.Haemocytometry.
Haemocytometry.globalsoin
 
Coomb's test
Coomb's testCoomb's test
Coomb's test
Nityanand Upadhyay
 
Romanowsky stain
Romanowsky stainRomanowsky stain
Romanowsky stain
sandeep singh
 

What's hot (20)

Myeloperoxidases Stains
Myeloperoxidases StainsMyeloperoxidases Stains
Myeloperoxidases Stains
 
Romanowsky stains
Romanowsky stainsRomanowsky stains
Romanowsky stains
 
blood group du testing
blood group du testing blood group du testing
blood group du testing
 
Pas staining
Pas staining Pas staining
Pas staining
 
PLATELET COUNT by Dr. Pandian M .pptx
PLATELET COUNT by Dr. Pandian M .pptxPLATELET COUNT by Dr. Pandian M .pptx
PLATELET COUNT by Dr. Pandian M .pptx
 
special and routine stains in haematology 1
special and routine stains in haematology 1special and routine stains in haematology 1
special and routine stains in haematology 1
 
Investigation of transfusion reaction
Investigation of transfusion reactionInvestigation of transfusion reaction
Investigation of transfusion reaction
 
Massons Trichrome Stain
Massons Trichrome StainMassons Trichrome Stain
Massons Trichrome Stain
 
Microtomes, Section cutting , Sharpening of Razors
Microtomes, Section cutting , Sharpening of RazorsMicrotomes, Section cutting , Sharpening of Razors
Microtomes, Section cutting , Sharpening of Razors
 
Bone marrow aspirate&biopsy preparation
Bone marrow aspirate&biopsy preparationBone marrow aspirate&biopsy preparation
Bone marrow aspirate&biopsy preparation
 
Reticulocyte count
Reticulocyte countReticulocyte count
Reticulocyte count
 
Staining ( rouine and special in cytology) rajiv kumar
Staining ( rouine and special in cytology) rajiv kumarStaining ( rouine and special in cytology) rajiv kumar
Staining ( rouine and special in cytology) rajiv kumar
 
Final ppt sickle cell
Final ppt sickle cellFinal ppt sickle cell
Final ppt sickle cell
 
Gel card technology ppt nc
Gel card technology ppt ncGel card technology ppt nc
Gel card technology ppt nc
 
coombs test
coombs testcoombs test
coombs test
 
Coombs test
Coombs testCoombs test
Coombs test
 
Special stain in histopathology
Special stain in histopathologySpecial stain in histopathology
Special stain in histopathology
 
Haemocytometry.
Haemocytometry.Haemocytometry.
Haemocytometry.
 
Coomb's test
Coomb's testCoomb's test
Coomb's test
 
Romanowsky stain
Romanowsky stainRomanowsky stain
Romanowsky stain
 

Similar to Demonstration of le cells

lasercyte-dx-dot-plot-poster-en-2.pdf
lasercyte-dx-dot-plot-poster-en-2.pdflasercyte-dx-dot-plot-poster-en-2.pdf
lasercyte-dx-dot-plot-poster-en-2.pdf
FlorinPosastiuc
 
Flow cytometry and fluorescence activated cell sorting (FACS)
Flow cytometry and fluorescence activated cell sorting (FACS)Flow cytometry and fluorescence activated cell sorting (FACS)
Flow cytometry and fluorescence activated cell sorting (FACS)
Abu Sufiyan Chhipa
 
Systemic lupus erythematosus - Dr Pranav
Systemic lupus erythematosus - Dr PranavSystemic lupus erythematosus - Dr Pranav
Systemic lupus erythematosus - Dr Pranav
Pranav S
 
Flow cytometry in diagnostics
Flow cytometry in diagnosticsFlow cytometry in diagnostics
Flow cytometry in diagnostics
Kaberi Nath
 
Flow cytometry
Flow cytometryFlow cytometry
Flow cytometry
bilal musharaf
 
resealed erythrocytes
 resealed erythrocytes  resealed erythrocytes
resealed erythrocytes Danish Kurien
 
Blood.pptx
Blood.pptxBlood.pptx
Blood.pptx
AreejAbdAlrahem
 
Hemolytic disorders due to inherited abnormalities in red cell cytoskeleton
Hemolytic disorders due to inherited abnormalities in red cell cytoskeletonHemolytic disorders due to inherited abnormalities in red cell cytoskeleton
Hemolytic disorders due to inherited abnormalities in red cell cytoskeleton
Guvera Vasireddy
 
Atlas on bethesda system for reporting cervical cytology
Atlas on bethesda system for reporting cervical cytologyAtlas on bethesda system for reporting cervical cytology
Atlas on bethesda system for reporting cervical cytology
Ashish Jawarkar
 
cpfrs1-3-converted.pptx
cpfrs1-3-converted.pptxcpfrs1-3-converted.pptx
cpfrs1-3-converted.pptx
salah126031
 
R PPT to Present-1ddddddddddddddddddddd.pptx
R PPT to Present-1ddddddddddddddddddddd.pptxR PPT to Present-1ddddddddddddddddddddd.pptx
R PPT to Present-1ddddddddddddddddddddd.pptx
dmfrmicro
 
Antinuclear antobdy testing
Antinuclear antobdy testingAntinuclear antobdy testing
Antinuclear antobdy testingLAB IDEA
 
Bethesda System for thyroid cytopathology
Bethesda System for thyroid cytopathologyBethesda System for thyroid cytopathology
Bethesda System for thyroid cytopathology
Precky Gabuat
 
Intorduction to Cytogenetics
Intorduction to CytogeneticsIntorduction to Cytogenetics
Intorduction to Cytogenetics
mohammadjamil37
 
Granulocytes in health and disease
Granulocytes in health and diseaseGranulocytes in health and disease
Granulocytes in health and disease
Kiran Gore
 
Rohan gupta 2015 b1ab651p facs
Rohan gupta 2015 b1ab651p   facsRohan gupta 2015 b1ab651p   facs
Rohan gupta 2015 b1ab651p facs
Rohan Gupta
 

Similar to Demonstration of le cells (20)

lasercyte-dx-dot-plot-poster-en-2.pdf
lasercyte-dx-dot-plot-poster-en-2.pdflasercyte-dx-dot-plot-poster-en-2.pdf
lasercyte-dx-dot-plot-poster-en-2.pdf
 
Flow cytometry and fluorescence activated cell sorting (FACS)
Flow cytometry and fluorescence activated cell sorting (FACS)Flow cytometry and fluorescence activated cell sorting (FACS)
Flow cytometry and fluorescence activated cell sorting (FACS)
 
Blood
Blood Blood
Blood
 
Systemic lupus erythematosus - Dr Pranav
Systemic lupus erythematosus - Dr PranavSystemic lupus erythematosus - Dr Pranav
Systemic lupus erythematosus - Dr Pranav
 
Flow cytometry in diagnostics
Flow cytometry in diagnosticsFlow cytometry in diagnostics
Flow cytometry in diagnostics
 
Flow cytometry
Flow cytometryFlow cytometry
Flow cytometry
 
resealed erythrocytes
 resealed erythrocytes  resealed erythrocytes
resealed erythrocytes
 
Blood.pptx
Blood.pptxBlood.pptx
Blood.pptx
 
Hemolytic disorders due to inherited abnormalities in red cell cytoskeleton
Hemolytic disorders due to inherited abnormalities in red cell cytoskeletonHemolytic disorders due to inherited abnormalities in red cell cytoskeleton
Hemolytic disorders due to inherited abnormalities in red cell cytoskeleton
 
Atlas on bethesda system for reporting cervical cytology
Atlas on bethesda system for reporting cervical cytologyAtlas on bethesda system for reporting cervical cytology
Atlas on bethesda system for reporting cervical cytology
 
cpfrs1-3-converted.pptx
cpfrs1-3-converted.pptxcpfrs1-3-converted.pptx
cpfrs1-3-converted.pptx
 
R PPT to Present-1ddddddddddddddddddddd.pptx
R PPT to Present-1ddddddddddddddddddddd.pptxR PPT to Present-1ddddddddddddddddddddd.pptx
R PPT to Present-1ddddddddddddddddddddd.pptx
 
Antinuclear antobdy testing
Antinuclear antobdy testingAntinuclear antobdy testing
Antinuclear antobdy testing
 
Bethesda System for thyroid cytopathology
Bethesda System for thyroid cytopathologyBethesda System for thyroid cytopathology
Bethesda System for thyroid cytopathology
 
8 traffic
8 traffic8 traffic
8 traffic
 
Intorduction to Cytogenetics
Intorduction to CytogeneticsIntorduction to Cytogenetics
Intorduction to Cytogenetics
 
Granulocytes in health and disease
Granulocytes in health and diseaseGranulocytes in health and disease
Granulocytes in health and disease
 
Rohan gupta 2015 b1ab651p facs
Rohan gupta 2015 b1ab651p   facsRohan gupta 2015 b1ab651p   facs
Rohan gupta 2015 b1ab651p facs
 
Blood
BloodBlood
Blood
 
Blood lecture 1
Blood lecture 1Blood lecture 1
Blood lecture 1
 

More from SHRUTHI VASAN

Diagnostic methods of Parasites
Diagnostic methods of ParasitesDiagnostic methods of Parasites
Diagnostic methods of Parasites
SHRUTHI VASAN
 
Clotting time - Coagulation of whole blood
Clotting time - Coagulation of whole bloodClotting time - Coagulation of whole blood
Clotting time - Coagulation of whole blood
SHRUTHI VASAN
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
SHRUTHI VASAN
 
Fnac of breast
Fnac of  breastFnac of  breast
Fnac of breast
SHRUTHI VASAN
 
cytology of urinary tract
cytology of urinary tractcytology of urinary tract
cytology of urinary tract
SHRUTHI VASAN
 
Antibodies
AntibodiesAntibodies
Antibodies
SHRUTHI VASAN
 
Microbes for biogoods
Microbes for biogoodsMicrobes for biogoods
Microbes for biogoods
SHRUTHI VASAN
 
Common diseases
Common diseasesCommon diseases
Common diseases
SHRUTHI VASAN
 
Histopathology - CRYOSTAT
Histopathology - CRYOSTATHistopathology - CRYOSTAT
Histopathology - CRYOSTAT
SHRUTHI VASAN
 
Anatomical techniques
Anatomical techniques Anatomical techniques
Anatomical techniques
SHRUTHI VASAN
 
Organization of laboratory
Organization of laboratoryOrganization of laboratory
Organization of laboratory
SHRUTHI VASAN
 

More from SHRUTHI VASAN (11)

Diagnostic methods of Parasites
Diagnostic methods of ParasitesDiagnostic methods of Parasites
Diagnostic methods of Parasites
 
Clotting time - Coagulation of whole blood
Clotting time - Coagulation of whole bloodClotting time - Coagulation of whole blood
Clotting time - Coagulation of whole blood
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Fnac of breast
Fnac of  breastFnac of  breast
Fnac of breast
 
cytology of urinary tract
cytology of urinary tractcytology of urinary tract
cytology of urinary tract
 
Antibodies
AntibodiesAntibodies
Antibodies
 
Microbes for biogoods
Microbes for biogoodsMicrobes for biogoods
Microbes for biogoods
 
Common diseases
Common diseasesCommon diseases
Common diseases
 
Histopathology - CRYOSTAT
Histopathology - CRYOSTATHistopathology - CRYOSTAT
Histopathology - CRYOSTAT
 
Anatomical techniques
Anatomical techniques Anatomical techniques
Anatomical techniques
 
Organization of laboratory
Organization of laboratoryOrganization of laboratory
Organization of laboratory
 

Recently uploaded

insect morphology and physiology of insect
insect morphology and physiology of insectinsect morphology and physiology of insect
insect morphology and physiology of insect
anitaento25
 
Structures and textures of metamorphic rocks
Structures and textures of metamorphic rocksStructures and textures of metamorphic rocks
Structures and textures of metamorphic rocks
kumarmathi863
 
Lab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerinLab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerin
ossaicprecious19
 
extra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdfextra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdf
DiyaBiswas10
 
Structural Classification Of Protein (SCOP)
Structural Classification Of Protein  (SCOP)Structural Classification Of Protein  (SCOP)
Structural Classification Of Protein (SCOP)
aishnasrivastava
 
platelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptxplatelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptx
muralinath2
 
FAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable PredictionsFAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable Predictions
Michel Dumontier
 
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
Sérgio Sacani
 
justice-and-fairness-ethics with example
justice-and-fairness-ethics with examplejustice-and-fairness-ethics with example
justice-and-fairness-ethics with example
azzyixes
 
Richard's entangled aventures in wonderland
Richard's entangled aventures in wonderlandRichard's entangled aventures in wonderland
Richard's entangled aventures in wonderland
Richard Gill
 
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
Health Advances
 
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
Scintica Instrumentation
 
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATIONPRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
ChetanK57
 
ESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptxESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptx
muralinath2
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Erdal Coalmaker
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
muralinath2
 
Large scale production of streptomycin.pptx
Large scale production of streptomycin.pptxLarge scale production of streptomycin.pptx
Large scale production of streptomycin.pptx
Cherry
 
plant biotechnology Lecture note ppt.pptx
plant biotechnology Lecture note ppt.pptxplant biotechnology Lecture note ppt.pptx
plant biotechnology Lecture note ppt.pptx
yusufzako14
 
erythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptxerythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptx
muralinath2
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
AlaminAfendy1
 

Recently uploaded (20)

insect morphology and physiology of insect
insect morphology and physiology of insectinsect morphology and physiology of insect
insect morphology and physiology of insect
 
Structures and textures of metamorphic rocks
Structures and textures of metamorphic rocksStructures and textures of metamorphic rocks
Structures and textures of metamorphic rocks
 
Lab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerinLab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerin
 
extra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdfextra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdf
 
Structural Classification Of Protein (SCOP)
Structural Classification Of Protein  (SCOP)Structural Classification Of Protein  (SCOP)
Structural Classification Of Protein (SCOP)
 
platelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptxplatelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptx
 
FAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable PredictionsFAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable Predictions
 
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
 
justice-and-fairness-ethics with example
justice-and-fairness-ethics with examplejustice-and-fairness-ethics with example
justice-and-fairness-ethics with example
 
Richard's entangled aventures in wonderland
Richard's entangled aventures in wonderlandRichard's entangled aventures in wonderland
Richard's entangled aventures in wonderland
 
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
 
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
 
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATIONPRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
 
ESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptxESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptx
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
 
Large scale production of streptomycin.pptx
Large scale production of streptomycin.pptxLarge scale production of streptomycin.pptx
Large scale production of streptomycin.pptx
 
plant biotechnology Lecture note ppt.pptx
plant biotechnology Lecture note ppt.pptxplant biotechnology Lecture note ppt.pptx
plant biotechnology Lecture note ppt.pptx
 
erythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptxerythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptx
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
 

Demonstration of le cells

  • 1. DEMONSTRATION OF LE CELLS PRESENTED BY, S.SHRUTHI VASAN III BSC.CLT Dr.NGP ARTS & SCIENCE COLLEGE
  • 2. LE CELLS:  An LE cell is a Neutrophil or Macrophage that has phagocytised (engulfed) the denatured nuclear material of another cell. The denatured material is an absorbed haematoxylin body (basophilic particle also called an LE body).  They are a characteristic of lupus erythematosus, but also found in similar connective tissue disorders.  The LE cell was discovered in bone marrow in 1948 by Malcolm McCallum Hargraves (1903–1982), a Physician and Practicing Histologist at the Mayo Clinic.  Classically, the LE cell is analyzed microscopically, but it is also possible to investigate this phenomenon by flow cytometry.
  • 4.
  • 5.
  • 6. SLE  Persons having lupus erythematosus, one of the "collagen" diseases, have an abnormal plasma protein that causes swelling and breakdown of certain blood cell nuclei in vitro.  This degenerated nuclear material attracts phagocytic cells, particularly segmented neutrophils, which engulf this nuclear mass.  The resulting phagocyte and inclusion material is termed an "L.E." cell.  Lupus erythematosus is a chronic, sometimes fatal, disease of unknown etiology.  The peculiar skin eruption across the nose and cheeks (butterfly rash) and arthritis can be accompanied by various visceral manifestations.  Often the rash is not present, and diagnosis depends on demonstration of the L.E. cell.  Frequently the earliest symptoms appear after intense exposure to sunlight.  Leukopenia, thrombocytopenia, and an elevated sedimentation rate are some of the clinical signs of the disease.
  • 7.
  • 8.
  • 9. Two methods of demonstrating the L.E. cell and antinuclear antibodies are the  Rotary bead method and  Fluorescent antibody method. The rotary bead method is positive in 75-80 erythematosus. The fluorescent antibody method is positive in 95-100 patients with lupus erythematosus. The fluorescent antibody method requires equipment that limits its use to larger laboratories.
  • 10. ROTARY BEAD METHOD Principle Leukocytes are broken down in vitro allowing the abnormal plasma protein to react on the altered nuclear material. Incubation enhances the nuclear deterioration and phagocytises. Slides are prepared and examined for the peculiar "L.E." cell.
  • 11.  Free masses of lysed nuclear material, with or without polymorphonuclear leukocytes clustered about them (rosette formation), are suggestive of the L.E. phenomenon.  Observing "rosettes" should encourage the technician to repeat examinations and further search for the true "L.E." cells.  A positive report should not be made without the identification of this cell. The inclusion body with the leukocyte is homogeneous and has no chromatin pattern. This feature distinguishes the true "L.E." cell from the "tart" cell (nucleophagocytosis).  This latter cell contains an engulfed, damaged nucleus, usually that of a lymphocyte, which still contains a recognizable chromatin pattern and a distinct nuclear membrane.
  • 12.
  • 13. COLLECTION OF SAMPLE:: Lupus erythematosus (LE) cell testing is performed using any of the following:  Heparinized bone marrow  Heparinized venous blood  Oxalated venous blood  Defibrinated venous blood  Clotted venous blood  LE factor and donor cells LE Factor: An Antibody found in the serum found in SLE Patients.
  • 14.  Obtaining bone marrow is usually distressing for the patient; therefore, the buffy coat from venous blood is an adequate substitute.  If the equipment for buffy coat is unavailable, an untreated venous blood sample is left to clot (from 20- 120 minutes) and the plasma removed. The residual clot is passed through a wire mesh and centrifuged for 5 minutes to obtain a buffy coat. This buffy coat is then smeared on glass slides to search for LE cells. [2]  The test may be performed by mixing the patient's plasma, serum, or serous effusions as a source of LE factor with bone marrow from a donor subject.
  • 15. CONSIDERATIONS:  The ideal temperature to perform this test is 22°C, and the process may be hastened by incubation at 37°C.
  • 16. INTERPRETATION o A lupus erythematosus (LE) cell test is considered positive when approximately 2%-30% of the cells seen on the slide in the neutrophil count are LE cells. o A smear is considered positive when 10 or more characteristic LE cells are seen during a 15-minute search, associated with the presence of extracellular, amorphous, nuclear masses. o The presence of LE cells indicates lupus. o Negative findings on LE cell testing exclude (deny) a diagnosis of systemic lupus erythematosus(SLE).
  • 17. o Positive reactions are also seen in 1. Rheumatoid arthritis 2. Chronic hepatitis(lupoid) 3. Scleroderma 4. Dermatomyositis 5. Polyarteritis nodosa 6. Acquired hemolytic anemia 7. Hodgkin disease o It may also be positive in persons taking phenylbutazone(Fever & RE) and hydralazine(BP)
  • 18. APPLICATION  Lupus erythematosus (LE) cell testing was once performed to diagnose systemic lupus erythematous but has been replaced for this purpose by antinuclear antibody testing.